Магнитно-резонансная томография сердца в дифференциальной диагностике кардиомиопатий
DOI: https://dx.doi.org/10.18565/therapy.2019.4.70-78
Е.А. Мершина
Медицинский научно-образовательный центр Московского государственного университета им. М.В. Ломоносова
В обзоре освещены вопросы диагностики кардиомиопатий с помощью метода магнитно-резонансной томографии (МРТ) сердца с отсроченным внутривенным контрастированием. Уделяется внимание различным формам гипертрофической кардиомиопатии, рассматриваются вопросы дифференциальной диагностики синдрома дилатационной кардиомиопатии (ДКМП), а также приводятся обновленные диагностические критерии аритмогенной дисплазии правого желудочка и МР-критерии миокардита. Различные виды кардиомиопатий проиллюстрированы клиническими примерами.
Литература
- Hundley W.G., Bluemke D.A., Finn J.P. et al. SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the american college of cardiology foundation task force on expert consensus documents. Circulation. 2010; 121: 2462–2508.
- Gonzalez J.A., Kramer C.M. Role of imaging techniques for diagnosis, prognosis and management of heart failure patients: cardiac magnetic resonance. Curr Heart Fail Rep 2015; 12: 276–283.
- Edelman R.R. et al. Clinical Magnetic Resonance Imaging, 3rd ed. New York: Elsevier Press; 2005.
- Soriano C.J., Ridocci F., Estornell J. et al. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance JACC. 2005; 45(5): 743–48.
- Rudolph A., Abdel-Aty H., Bohl S. et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. JACC. 2009; 53(3): 284-91.
- Moon J.C., Messroghli D.R., Kellman P. et al. Myocardial T1 mapping and extracellular volume quantification: SCMR and CMR Working Group of the ESC consensus statement. JCMR. 2013; 15: 92.
- Elliott P.M., Anastasakis A., Borger M.A., Borggref M. et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. EHJ. 2014; 35: 2733–79.
- Green J.J., BergerJ.S., Kramer C.M., Salerno M. Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012; 5: 370–77.
- Prinz C., Schwarz M., Ilic I. et al. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Can J Cardiol. 2013; 29: 358–63.
- Maron M.S., Finley J.J., Bos J.M., Hauser T.H. et al. Prevalence, clinical significance and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation 2008; 118: 1541–49.
- Brouwer W.P., Germans T., Head M.C. et al. Multiple myocardial crypts on modified long-axis view are a specific finding in pre-hypertrophic HCM mutation carriers. EHJ Cardiovasc Imaging. 2012; 13: 292–97.
- Maron M.S., Rowin E.J., Lin D. et al. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2012; 5: 441–47.
- Yu E.H., Omran A.S., Wigle E.D. et al. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am CollCardiol. 2000; 36: 2219–25.
- Valeti U.S., Nishimura R.A., Holmes D.R. et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. JACC. 2007; 49: 350–57.
- McCrohon J.A., Moon J.C., Prasad S.K., McKenna W.J., Lorenz C.H., Coats A.J., Pennell D.J. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003, 108: 54–59.
- Schalla S., Bekkers S.C., Dennert R. et al. Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail. 2010; 12: 227–31.
- Voigt A., Elgeti T., Durmus T. et al. Cardiac magnetic resonance imaging in dilated cardiomyopathy in adults—toward identification of myocardial inflammation. Eur Radiol. 2011; 21(5): 925–35.
- Sechtem U., Mahrholdt H., Vogelsberg H. Cardiac magnetic resonance in myocardial disease. Heart. 2007; 93: 1520–27.
- Mahrholdt H., Goedecke C., Wagner A. Cardiovascular magnetic resonance assessment of human myocarditis; a comparison to histology and molecular pathology. Circulation. 2004; 109: 1250–58.
- Friedrich M.G. et al. Cardiovascular magnetic resonance in myocarditis. A JACC White Paper. JACC. 2009; 53 (17): 1475–87.
- Lagan J., Schmitt M., Miller C.A. Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases. Int J Cardiovasc Imaging. 2018; 34(1): 35–54.
- Rammos A., Meladinis V., Vovas G. et al. Restrictive Cardiomyopathies: The Importance of Noninvasive Cardiac Imaging Modalities in Diagnosis and Treatment—A Systematic Review. Radiol Res Pract. 2017.
- Aquaro G.D., Pingitore A., Di Bella G. et al. Prognostic Role of Cardiac Magnetic Resonance in Arrhythmogenic Right Ventricular Cardiomyopathy. AJC 2018; 122(10): 1745–53.
- Marcus F.I., McKenna W.J., Sherrill D. et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: Proposed Modification of the Task Force Criteria EHJ 2010; 31(7): 806–14.
- Petersen S., Selvanayagam J., Wiesmann F. et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. JACC 2005; 46(1): 101–05.
- Jacquier A., Thuny F., Jop B. et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J 2010; 31(9): 1098–1104.
- Probst S., Oechslin E., Schuler P. et al. Sarcomere gene mutations in isolated left ventricular noncompation cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet., 2011
- Hoedemaekers Y., Caliskan K., Michels M. et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet. 2010; 3: 232–39.
Об авторах / Для корреспонденции
Елена Александровна Мершина, зав. отделением рентгенодиагностики с кабинетами МРТ и КТ, в.н.с. отдела лучевой диагностики Медицинского научно-образовательного центра Московского государственного университета им. М.В. Ломоносова. Адрес: 119192, г. Москва, Ломоносовский пр-т, д. 27, к. 10. Тел.: 8 (495) 531-27-27. E-mail: elena_mershina@mail.ru
Похожие статьи